Statin
Mevalonate pathway inhibition slows breast cancer metastasis via reduced N-glycosylation abundance and branching
https://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.png 396 361 Penn Lab Penn Lab https://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.pngStatins as Anticancer Agents in the Era of Precision Medicine
https://pennlab.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 Penn Lab Penn Lab https://pennlab.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg
Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death
https://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png 952 562 Penn Lab Penn Lab https://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
https://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper.png 621 267 Penn Lab Penn Lab https://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper.png